title: Multidisciplinary intervention for control of diabetes in patients undergoing coronary artery bypass graft (CABG).
abstract: In Israel, as elsewhere, diabetes mellitus is highly prevalent among patients undergoing coronary artery bypass graft (CABG). The bulk of evidence, derived retrospectively, suggests that poor control of diabetes predisposes to complications of CABG and increases mortality; but the findings in a number of studies fail to support that impression. Anticipating a prospective investigation designed to resolve this issue, we have carried out a preliminary study of 147 consecutive patients with diabetes who were hospitalized for elective CABG during 1998. Our objective was to determine how well and how often diabetes could be controlled in accordance with selected metabolic goals in the brief interval between hospital admission and surgery and during the operation itself and in the postoperative period. The task was undertaken by a multidisciplinary team, in cooperation with the Department of Cardiac Surgery. The metabolic goals were: fasting blood glucose consistently between 65-140 mg/dl before and after surgery and 120-180 mg/dl at the time of surgery; and postprandial blood glucose consistently <180 mg/dl. These goals were achieved in 18.1% of fasting blood glucose measurements before and after surgery, 22.1% of preprandial and 14.6% of postprandial blood glucose levels consistently <180 mg/dl. There were no clinical episodes of hypoglycemia. Due to the low incidence of major infection related complications (deep sternal wound infection in only 3 patients (2.0%)) no significant statistical conclusions on the relations between glucose control and these complications could be drawn. The means of all values of FBG and of hemoglobin A1c were significantly higher among patients with complications (n=49) than in those without (P=0.01).
authors.affiliation: Institute of Endocrinology, Sheba Medical Center, Tel-Hashomer, Israel. ohdcohen@sheba.health.gov.il
authors.forename: Ohad
authors.initials: O
authors.lastname: Cohen
authors.forename: Rachel
authors.initials: R
authors.lastname: Dankner
authors.forename: Angela
authors.initials: A
authors.lastname: Chetrit
authors.forename: Osnat
authors.initials: O
authors.lastname: Luxenburg
authors.forename: Claude
authors.initials: C
authors.lastname: Langenauer
authors.forename: Amihay
authors.initials: A
authors.lastname: Shinfeld
authors.forename: Aram K
authors.initials: AK
authors.lastname: Smolinsky
mesh_terms: D000368:Aged; D016009:Chi-Square Distribution; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000150:complications / Q000601:surgery; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000601:surgery; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010347:Patient Care Planning; D010865:Pilot Projects; D011184:Postoperative Period; D013530:Surgical Wound Infection / Q000517:prevention & control
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin